hesperidin has been researched along with Injury, Myocardial Reperfusion in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, A; Luo, Q; Zhang, X | 1 |
| Chen, A; He, S; Ling, Y; Tan, Z; Tang, L; Wang, X; Yang, P; Zhang, Y; Zhong, Y | 1 |
| Hu, X; Jiang, H; Li, X; Ma, R; Wang, J; Xu, W; Yi, C | 2 |
| Balaraman, R; Gandhi, C; Upaganalawar, A | 1 |
| Bhatnagar, A; Kaiserova, K; Srivastava, S; Tang, XL | 1 |
6 other study(ies) available for hesperidin and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Neohesperidin alleviated pathological damage and immunological imbalance in rat myocardial ischemia-reperfusion injury via inactivation of JNK and NF-κB p65.
Topics: Animals; Hesperidin; JNK Mitogen-Activated Protein Kinases; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transcription Factor RelA | 2021 |
Hesperetin post-treatment prevents rat cardiomyocytes from hypoxia/reoxygenation injury in vitro via activating PI3K/Akt signaling pathway.
Topics: Animals; Apoptosis; Cardiotonic Agents; Caspase 3; Cell Survival; Hesperidin; Hypoxia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2017 |
Inhibition of autophagy via activation of PI3K/Akt/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia/reperfusion injury.
Topics: Animals; Autophagy; Hesperidin; Male; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Short-Term Hesperidin Pretreatment Attenuates Rat Myocardial Ischemia/Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein Expression via the PI3K/Akt Pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Cardiotonic Agents; Chromones; Drug Administration Schedule; Drug Dosage Calculations; Gene Expression Regulation; Hesperidin; HMGB1 Protein; Male; Morpholines; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2016 |
Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Arrhythmias, Cardiac; Biomarkers; Blood Pressure; Catalase; Creatine Kinase, MB Form; Disease Models, Animal; Electrocardiography; Female; Glutathione; Heart Rate; Hesperidin; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitrites; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Ventricular Pressure | 2009 |
Role of nitric oxide in regulating aldose reductase activation in the ischemic heart.
Topics: Aldehyde Reductase; Animals; Bradykinin; Dithiothreitol; Enzyme Activation; Enzyme Inhibitors; Ferric Compounds; Glucose; Hesperidin; Hypoglycemic Agents; Imidazolidines; Insulin; Lipid Peroxidation; Male; Metalloporphyrins; Myocardial Reperfusion Injury; Myocardium; Naphthalenes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Sorbitol; Vasodilator Agents | 2008 |